Medtronic Canada recognized among Canada's Top 100 Employers for 2022

Learning and development opportunities & focus on Mission among reasons for selection

 Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) a global leader in healthcare technology, today announced it has been recognized by MediaCorp as one of Canada's Top 100 Employers.

Medtronic Canada (CNW Group/Medtronic Canada ULC)

This national competition determines which employers across Canada lead their industries in offering exceptional workplaces for their employees. Now in its 22nd annual edition, Canada's Top 100 Employers highlights the most progressive and forward-thinking companies, evaluated on a set of eight criteria.

"Contributing to human welfare is the backbone of Medtronic's identity," said Neil Fraser , president of Medtronic Canada. "Our mission challenges us not only to improve the lives of the patients we serve, but also the lives of our employees."

Medtronic has always prioritized learning and development initiatives for its workforce, as well as diversity and inclusion through its active enhancement programs, networking circles and employee-run resource groups.

Despite the chaos caused by the pandemic, the company has continued to offer personnel opportunities to advance their careers at all levels and live the company's Mission — to alleviate pain, restore health, and extend life.

"We are proud of our employees' commitment to healthcare innovation," adds Fraser. "The desire to make a positive impact in people's lives is generally what motivates talent to join us -- and we do our best to ensure we keep that talent on board."

Melissa Louis , marketing manager in the Diabetes business, agrees. After graduating from university in 2006, she launched her career at Medtronic and made the most of the professional development resources provided by the company from day one. After progressive promotions over the years, she now leads her own team -- her upwards trajectory has not been slowed by the pandemonium of COVID19.

"Medtronic has stayed committed to its core values since I started and throughout the pandemic," said Louis. "The company's focus on improving people's health and quality of life hasn't changed, and Medtronic supports its employees every step of the way."

About Medtronic Canada ULC

Bold thinking. Bolder actions. We are Medtronic.  Proud to serve Canadian healthcare for over 50 years, Medtronic Canada ULC is headquartered in Brampton, Ontario , with regional offices in Montreal and Vancouver , and is a subsidiary of Medtronic plc. We are the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Our technologies and therapies address 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for all. In everything we do, we are engineering the extraordinary. For more information on Medtronic Canada, visit www.Medtronic.c a and follow @MedtronicCA on Twitter and LinkedIn .

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Courtesy of Mediacorp Canada Inc. (CNW Group/Medtronic Canada ULC)

SOURCE Medtronic Canada ULC

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/November2021/12/c3374.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×